This inventor holds 1 USPTO granted patent. Top assignee: Aurobindo Pharma Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Mahendar Reddy Nayini: Innovator in Pharmaceutical Chemistry
Introduction
Mahendar Reddy Nayini is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of important medicinal compounds. His work has led to the development of innovative processes that enhance the purity and efficacy of pharmaceutical products.
Latest Patents
Mahendar Reddy Nayini holds a patent for a process for the preparation of Valsartan. This invention relates to a method that produces pure Valsartan substantially free from impurities. The process involves several steps, including the condensation of specific chemical compounds, treatment with acid and base, and hydrolysis under alkaline conditions. This innovative approach ensures the production of high-quality Valsartan, which is crucial for its effectiveness as a medication.
Career Highlights
Mahendar Reddy Nayini is currently employed at Aurobindo Pharma Limited, a leading pharmaceutical company known for its commitment to quality and innovation. His role at the company allows him to apply his expertise in pharmaceutical chemistry to develop new and improved processes for drug manufacturing.
Collaborations
Throughout his career, Mahendar has collaborated with talented professionals in the field. Notable coworkers include Raveendra Reddy Chinta and Gangadhara Bhima Shankar Nangi, who have contributed to various projects alongside him.
Conclusion
Mahendar Reddy Nayini's contributions to pharmaceutical chemistry, particularly through his patent for the preparation of Valsartan, highlight his innovative spirit and dedication to improving drug quality. His work at Aurobindo Pharma Limited continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
